Cargando…
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
The elderly population in the United States is projected to almost double by the year 2050. In addition, the numbers of diabetics are rising, along with its most common complication, diabetic retinopathy (DR). To effectively treat DR within the elderly population, it is essential first to consider t...
Autores principales: | Leley, Sameer P, Ciulla, Thomas A, Bhatwadekar, Ashay D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289197/ https://www.ncbi.nlm.nih.gov/pubmed/34290499 http://dx.doi.org/10.2147/CIA.S297494 |
Ejemplares similares
-
Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World
por: Bhatwadekar, Ashay D., et al.
Publicado: (2021) -
Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022) -
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
por: Luo, Qianyi, et al.
Publicado: (2022) -
miR-92a and integrin expression in fibrovascular membranes in proliferative diabetic retinopathy
por: Luo, Qianyi, et al.
Publicado: (2023) -
Effect of the pharmacist-managed cardiovascular risk reduction
services on diabetic retinopathy outcome measures
por: Weber, Zachary A., et al.
Publicado: (2019)